Oncology Institute Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Oncology Institute Inc had 30.28M in cash and cash equivalents.

Oncology Institute Inc reported 180.38M in total liabilities as of the latest reported quarter, including 70.96M in current liabilities and 109.41M in non-current liabilities.

As of the latest reported quarter, Oncology Institute Inc's total assets were 164.66M, consisting of 112.75M in current assets and 51.91M in non-current assets.

Oncology Institute Inc reported -15.72M in total shareholders' equity as of the latest reported quarter.